Deborah Marshall is an Oncology physician affiliated with Johnson & Johnson. OpenAlex indexes 17 publications with 652 citations (h-index 11); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1 Gustave L Levy Pl
New York, NY 100296504
Telephone
212-241-7500Provider last certified this registry record 30 Sept 2021.
Clinical trials
- A Multi Center Study of Sexual Toxicities After Radiotherapy
Sponsor: Icahn School of Medicine at Mount Sinai
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
1 NIH research award on record, funded 2021–2025 per NIH RePORTER. The latest:
- Novel Functional Anatomic and Biomarker Indices of Radiation-Induced Female Sexual Toxicities in a Multi-Center Cohort
Icahn School of Medicine at Mount Sinai
FY2025$413,287DP5OD031876 - Novel Functional Anatomic and Biomarker Indices of Radiation-Induced Female Sexual Toxicities in a Multi-Center Cohort
Icahn School of Medicine at Mount Sinai
FY2024$413,287DP5OD031876 - Novel Functional Anatomic and Biomarker Indices of Radiation-Induced Female Sexual Toxicities in a Multi-Center Cohort
Icahn School of Medicine at Mount Sinai
FY2023$413,287DP5OD031876
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Integrin receptors on tumor cells facilitate NK cell‐mediated antibody‐dependent cytotoxicity
European Journal of Immunology
2014 - Expression of αV-Integrins in Uterine Serous Papillary Carcinomas; Implications for Targeted Therapy With Intetumumab (CNTO 95), a Fully Human Antagonist Anti – αV-Integrin Antibody
International Journal of Gynecological Cancer
2011
Similar KOLs
Other experts from the same institution or the same specialty.
Wayne Drevets, MD
Johnson & Johnson
Matthew Breyer, MD
Johnson & Johnson
Deepu Madduri, MD
Johnson & Johnson
Elliot Barnathan, MD
Johnson & Johnson
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”